Corporate Presentation

MediPharm Labs CANOPY GROWTH TIY CORPORATION Significant Cannabis Oil Sale Agreement with Canopy Growth Corporation ● ● ● ● First sale to world's largest cannabis company demonstrates strong endorsement of MediPharm's specialized extraction model MediPharm will refine its own inventory of dried flower into high quality cannabis oil extract for sale to Canopy Growth Agreement is for an initial purchase commitment of 450kg and additional purchase options for 450kg, for total volume of up to 900kg of cannabis oil extract First instalment of committed purchase of cannabis oil extract to be delivered by the end of fiscal Q4 2018 Balance of oil purchase commitments are scheduled to occur monthly through 2019. Additional purchase options available from January 2019 through mid-2020 Agreement represents less than 5% of MediPharm's expected annual processing capacity of approximately 250,000 kg scheduled to be completed end of Q2 2019 Significant excess capacity to fulfill the role as an agnostic supplier of pharma-grade cannabis oil concentrates to the global cannabis industry MediPharm Labs | 15

View entire presentation